Altrinsic Global Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

Altrinsic Global Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-70,286	Closed	-$1.19M	–	85
2019 Q4	$1.19M	Sell	70,286 -50,000	-42%	-$930K	0.05%	64
2019 Q3	$1.85M	Hold	120,286	–	–	0.08%	54
2019 Q2	$2.82M	Buy	120,286 +70,000	+139%	+$1.73M	0.13%	51
2019 Q1	$1.43M	Sell	50,286 -25,000	-33%	-$728K	0.07%	67
2018 Q4	$2.27M	Sell	75,286 -20,000	-21%	-$561K	0.11%	54
2018 Q3	$3.34M	Sell	95,286 -102,514	-52%	-$3.1M	0.15%	52
2018 Q2	$4.69M	Buy	197,800 +10,000	+5%	+$239K	0.19%	49
2018 Q1	$4.81M	Buy	187,800 +37,800	+25%	+$814K	0.19%	47
2017 Q4	$2.6M	Buy	150,000 +25,000	+20%	+$490K	0.1%	60
2017 Q3	$3.46M	Buy	+125,000	New	+$2.31M	0.13%	60

Other funds holding AKCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Altrinsic Global Advisors's AKCA Position: Q1 2020 in Review

Altrinsic Global Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q1 2020, closing a stake of 70,286 shares — an estimated $1.19M sold.

Altrinsic Global Advisors first reported a position in AKCA in Q3 2017 and held it in 10 quarters. The position peaked at $4.81M in Q1 2018. 77 funds tracked by Wall St. Rank hold AKCA as of Q1 2020.

Altrinsic Global Advisors reported no remaining Akcea Therapeutics Inc position as of Q1 2020 after selling out during the quarter.
Altrinsic Global Advisors sold 70,286 Akcea Therapeutics Inc shares in Q1 2020, an estimated $1.19M.
Altrinsic Global Advisors first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 10 quarters.
Altrinsic Global Advisors's Akcea Therapeutics Inc position peaked at $4.81M in Q1 2018.
77 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2020.

Based on Altrinsic Global Advisors's 13F filing for Q1 2020, filed 14 May 2020.